AC Immune (ACIU) Return on Sales Growth (1y) (2016 - 2026)

AC Immune (ACIU) Return on Sales Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn - -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 976.78 Bn 976.78 Bn - -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn 0.00
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 0.00
7 Belite Bio 63.06 Bn 63.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 0.00
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn 0.00
10 AC Immune 231.23 Mn 231.23 Mn - 6.00

Historic Data

Download Data
DateValue
Mar 31, 2026 6.00
Dec 31, 2025 -29.00
Sep 30, 2025 -17.00
Jun 30, 2025 17.00
Dec 31, 2020 2.00
Sep 30, 2020 -25.00
Jun 30, 2020 -3.00
Mar 31, 2020 -1.00
Dec 31, 2019 -10.00
Sep 30, 2019 14.00
Jun 30, 2019 -6.00
Mar 31, 2019 9.00
Dec 31, 2018 -13.00
Sep 30, 2018 3.00
Jun 30, 2018 10.00
Mar 31, 2018 -8.00
Dec 31, 2017 -8.00
Sep 30, 2017 -2.00
Jun 30, 2017 -21.00
Mar 31, 2017 13.00